Livanos House, Granhams Road Cambridge CB2 5LQ
Tel: (01223) 843899 Fax: (01223) 843325
in the Future of Alzheimer's Disease
ART has established
in the centres of the Network a PhD programme in
which the brightest and best embryo scientists are obtaining postgraduate education
and research training in a first class AD research environment to prepare them
for careers as the next generation of AD researchers. These students are doing
valuable research as part of their training, as well as developing the skills
to operate independently in future. ARTs appeal with the help of The Times funded a PhD at Cardiff to look at risk factors for Alzheimers disease.
A further three PhDs were funded with the help of Charitable Trusts in 1999. A
further three PhDs have now begun work:
Lloyd - University of Wales College of Medicine in Cardiff. The Cardiff
PhD, funded by readers of The Times looks at genetic risk factors,
specifically the involvement of Angiotensin - converting enzyme in Alzheimer's
- Institute of Neurology, University College London. Funded by the
Band Trust, Rachael is researching the analysis of magnetic resonance imaging
volume data sets (a diagnostic and measuring tool)
||Julia Thomas - University
of Oxford - funded by the A & S Burton 1960 Charitable Trust, this PhD
for research into the effects of homocysteine on potassium channel function
in platelets (leading to possible methods to prevent Alzheimer's disease)
||Kimberly Hodinott - University
of Aberdeen. Thanks to Lloyds TSB Foundation for Scotland, the Robertson Trust and an
anonymous donor, this PhD studies modelling of Tau protein (part of the
classic pathology of Alzheimer's disease).
The PhDs which started in October 2000 are:
Small - University of Dundee. The role of nitric oxide
synthase as a component of the inflammatory response associated with Alzheimer's
||Claudie Hooper- Institute of Neurology, University College London.
With the support of The Haberdashers' Pinchin Foundation, the project is
researching the interplay between stroke and Alzheimer's disease.
||Orla Teahan - University
of Newcastle. Researching the impact of cerebrovascular disease on Alzheimer's pathology in the elderly.
|The new PhD projects to begin in October 2001 are as follows:
||Manchester - the pathway to y secretase dependent cleavage of he B amyloid precursor protien
||Cambridge - the early diagnosis of AD and related dmentias using tests of naming people and cross-modal associative learning
||Inst of Pscyhiatry, London - Insulin signalling - coupling APP metabolism to Tau phosphorylation
The cost of a full PhD is £57,000.
We are happy to discuss the naming of a studentship after trusts or individuals.
Contact Rebecca Wood, Chief Executive, Alzheimer's Research Trust, Livanos House,
Granhams Road, Cambridge CB2 5LQ or email email@example.com